Kensuke Tateishi
- Genetics top 2%
- Glioma Diagnosis and Treatment 29
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 9
-
- Neuropeptides and Animal Physiology 10
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 5
- Neurofibromatosis and Schwannoma Cases 5
-
- Meningioma and schwannoma management 6
-
- Head and Neck Surgical Oncology 5
-
- Histone Deacetylase Inhibitors Research 4
- Co-authors
- Takafumi HamaokaE HashimuraDaniel P. CahillHiroaki WakimotoNobutaka KawaharaM. TohyamaSadao ShiosakaKoichi Ichimura
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Kensuke Tateishi
65 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 96
- Genetics 540
- Cancer Research 320
- Endocrine and Autonomic Systems 140
- Cellular and Molecular Neuroscience 368
- Neurology 182
Countries citing papers authored by Kensuke Tateishi
This map shows the geographic impact of Kensuke Tateishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Tateishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Tateishi more than expected).
Fields of papers citing papers by Kensuke Tateishi
This network shows the impact of papers produced by Kensuke Tateishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Tateishi. The network helps show where Kensuke Tateishi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kensuke Tateishi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 0 | |
| 8 | 2020 | 43 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 19 | |
| 11 | 2019 | 3 | |
| 12 | 2018 | 15 | |
| 13 | 2018 | 3 | |
| 14 | 2017 | 73 | |
| 15 | 2017 | 7 | |
| 16 | 2016 | 119 | |
| 17 | 2016 | 9 | |
| 18 | 2014 | 130 | |
| 19 | 2014 | 17 | |
| 20 | 2013 | 15 |
About Kensuke Tateishi
Kensuke Tateishi is a scholar working on Genetics, Neurology and Cellular and Molecular Neuroscience, having authored 69 papers that have together received 1.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (29 papers), Neuropeptides and Animal Physiology (10 papers), Cancer, Hypoxia, and Metabolism (9 papers), Meningioma and schwannoma management (6 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), Head and Neck Surgical Oncology (5 papers), Neurofibromatosis and Schwannoma Cases (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Genetics (540 citations), Cancer Research (320 citations) and Endocrine and Autonomic Systems (140 citations). Kensuke Tateishi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takafumi Hamaoka, E Hashimura, Daniel P. Cahill, Hiroaki Wakimoto, Nobutaka Kawahara, M. Tohyama, Sadao Shiosaka, Koichi Ichimura, Shintaro Fukushima and Yasuji Miyakita.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.